Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles.

Por Halpern, Z, Moshkowitz, M, Laufer, H, Peled, Y, Gilat, T
Publicado em 1993

Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients

Por Rosner, G, Lurie, Y, Blendis, L, Halpern, Z, Oren, R
Publicado em 2006

Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.

Por Bar-Meir, S, Halpern, Z, Gutman, M, Shpirer, Z, Baratz, M, Bass, D
Publicado em 1985

The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

Por Bruck, R., Hershkoviz, R., Lider, O., Shirin, H., Aeed, H., Halpern, Z.
Publicado em 1997

Ileitis after colectomy for ulcerative colitis or carcinoma.

Por Hallak, A, Baratz, M, Santo, M, Halpern, Z, Rabau, M, Werbin, N, Gilat, T
Publicado em 1994

Effect of lipid infusion on bile composition and lithogenicity in patients without cholesterol gall stones.

Por Rubin, M, Halpern, Z, Charach, G, Dvir, A, Antebi, E, Gilat, T, Lichtenberg, D
Publicado em 1992

Stability of mixed micellar bile models supersaturated with cholesterol.

Por Lichtenberg, D, Ragimova, S, Bor, A, Almog, S, Vinkler, C, Kalina, M, Peled, Y, Halpern, Z
Publicado em 1988

Fatty acid bile acid conjugates (FABACs)—New molecules for the prevention of cholesterol crystallisation in bile

Por Gilat, T, Somjen, G, Mazur, Y, Leikin-Frenkel, A, Rosenberg, R, Halpern, Z, Konikoff, F.
Publicado em 2001

Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.

Por Bruck, R, Shirin, H, Hershkoviz, R, Lider, O, Kenet, G, Aeed, H, Matas, Z, Zaidel, L, Halpern, Z
Publicado em 1997